Search ⌘K
Tipsheet
An editorial reading of India’s listed companies.
Brief /Concalls / Specialty Chemicals

Gulshan Polyols targets ₹5,000 cr revenue within four years

Management is betting ₹500 cr on a new specialty chemicals plant in Madhya Pradesh to double the company's top line.

1 earlier story on Gulshan Polyols Ltd.
₹5,000 cr Four-year revenue target set by management.

What's new

  • Management guided for FY27 revenue of ₹2,600-2,800 cr.
  • EBITDA margins for FY27 are expected at 10-12%.
  • A ₹500 cr capex plan for a new Madhya Pradesh specialty chemicals facility was disclosed.

Why it matters

Management is pinning its expansion on a ₹500 cr bet into specialty chemicals. Whether the company reaches its ₹5,000 cr four-year revenue goal hinges on the successful, timely commissioning of this facility.

What we're watching

  • Construction timelines for the new Madhya Pradesh plant.
  • Quarterly updates on margin stabilization against the 10-12% target.
  • Any updates on funding mix for the ₹500 cr project.

The full read

Gulshan Polyols is leaning into a multi-year growth plan, committing ₹500 crore to a new specialty chemicals facility in Madhya Pradesh. During its May 22 investor call, management set a firm target to reach ₹5,000 crore in annual revenue within four years. For the immediate future, FY27 guidance sits between ₹2,600 crore and ₹2,800 crore, with management expecting EBITDA margins to settle between 10% and 12%. Profitability projections are narrower, with PAT margins expected at 5-6%. The company is essentially using this capex to diversify its portfolio, yet the success of these ambitious revenue targets relies heavily on how quickly the new capacity ramps up and finds its market. The next test is how efficiently the company deploys its capital toward the new site.

Mentioned: Gulshan Polyols · Madhya Pradesh
Primary source BSE filings for GULPOLY NSE filings for GULPOLY Research GULPOLY on Tijori Finance Our reading is derived from the exchange filing. Verify on the exchange before acting.